P

Pharmx Technologies Ltd
ASX:PHX

Watchlist Manager
Pharmx Technologies Ltd
ASX:PHX
Watchlist
Price: 0.15 AUD 3.45% Market Closed
Market Cap: 89.9m AUD
Section:
 

Relative Value

The Relative Value of one PHX stock under the Base Case scenario is 0.03 AUD. Compared to the current market price of 0.15 AUD, Pharmx Technologies Ltd is Overvalued by 81%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHX Relative Value
Base Case
0.03 AUD
Overvaluation 81%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

12.3
P/S
P/S
Price to Sales
12.3
vs History
1
vs Industry
20
Median 3Y
5.5
Median 5Y
3.6
Industry
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
2
Median 3Y
-18.9
Median 5Y
-7.3
Industry
22.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
60
Median 3Y
1.9
Median 5Y
5.6
Industry
16.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
47
Median 3Y
-5.5
Median 5Y
-10.8
Industry
20.7
More Details
5.6
P/B
P/B
Price to Book Value
5.6
vs History
1
vs Industry
41
Median 3Y
1.5
Median 5Y
1.5
Industry
2.9
More Details
11.8
EV/S
EV/S
Enterprise Value to Sales
11.8
vs History
1
vs Industry
21
Median 3Y
2
Median 5Y
2.3
Industry
2.4
More Details
14.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
14.5
vs History
1
vs Industry
32
Median 3Y
2.8
Median 5Y
2.8
Industry
4.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
3
Median 3Y
-12.8
Median 5Y
-12.8
Industry
12.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
2
Median 3Y
-12.8
Median 5Y
-12.8
Industry
15.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
61
Median 3Y
0.7
Median 5Y
3.8
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
50
Median 3Y
-5.1
Median 5Y
-10.5
Industry
17.3
More Details
6.4
EV/IC
EV/IC
Enterprise Value to IC
6.4
vs History
1
vs Industry
32
Median 3Y
2.2
Median 5Y
1.6
Industry
2.4
More Details

Multiples Across Competitors

PHX Competitors Multiples
Pharmx Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Pharmx Technologies Ltd
ASX:PHX
89.8m AUD 12.3 -340.1 -861.4 -861.4
US
Ezenia! Inc
OTC:EZEN
567B USD 233 910.9 -180 630.8 -182 667.2 -177 298
US
Palantir Technologies Inc
NYSE:PLTR
412.9B USD 106 376.9 464.1 478.4
DE
SAP SE
XETRA:SAP
237.3B EUR 6.5 33.5 20.6 23.3
US
Salesforce Inc
NYSE:CRM
241.4B USD 6 33.4 19.4 26.9
US
Applovin Corp
NASDAQ:APP
214.3B USD 38.8 75.7 60.1 65.3
US
Intuit Inc
NASDAQ:INTU
176.5B USD 9.1 42.9 29.7 34.3
US
Adobe Inc
NASDAQ:ADBE
138.8B USD 5.8 19.5 14.5 15.9
US
NCR Corp
LSE:0K45
129B USD 48.7 -2 115 366.8 1 073
US
Synopsys Inc
NASDAQ:SNPS
91.7B USD 14.2 45.9 72.3 93.6
US
Cadence Design Systems Inc
NASDAQ:CDNS
82.1B USD 15.7 77.4 43.9 49.7
P/S Multiple
Revenue Growth P/S to Growth
AU
P
Pharmx Technologies Ltd
ASX:PHX
Average P/S: 21 288.5
12.3
N/A N/A
US
Ezenia! Inc
OTC:EZEN
233 910.9
N/A N/A
US
Palantir Technologies Inc
NYSE:PLTR
106
46%
2.3
DE
SAP SE
XETRA:SAP
6.5
11%
0.6
US
Salesforce Inc
NYSE:CRM
6
10%
0.6
US
Applovin Corp
NASDAQ:APP
38.8
29%
1.3
US
Intuit Inc
NASDAQ:INTU
9.1
13%
0.7
US
Adobe Inc
NASDAQ:ADBE
5.8
10%
0.6
US
N
NCR Corp
LSE:0K45
48.7
-8%
N/A
US
Synopsys Inc
NASDAQ:SNPS
14.2
21%
0.7
US
Cadence Design Systems Inc
NASDAQ:CDNS
15.7
14%
1.1
P/E Multiple
Earnings Growth PEG
AU
P
Pharmx Technologies Ltd
ASX:PHX
Average P/E: 88.1
Negative Multiple: -340.1 		N/A N/A
US
Ezenia! Inc
OTC:EZEN
Negative Multiple: -180 630.8 N/A N/A
US
Palantir Technologies Inc
NYSE:PLTR
376.9
94%
4
DE
SAP SE
XETRA:SAP
33.5
48%
0.7
US
Salesforce Inc
NYSE:CRM
33.4
32%
1
US
Applovin Corp
NASDAQ:APP
75.7
61%
1.2
US
Intuit Inc
NASDAQ:INTU
42.9
31%
1.4
US
Adobe Inc
NASDAQ:ADBE
19.5
21%
0.9
US
N
NCR Corp
LSE:0K45
Negative Multiple: -2 115
-49%
N/A
US
Synopsys Inc
NASDAQ:SNPS
45.9
13%
3.5
US
Cadence Design Systems Inc
NASDAQ:CDNS
77.4
34%
2.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
P
Pharmx Technologies Ltd
ASX:PHX
Average EV/EBITDA: 121.3
Negative Multiple: -861.4 		N/A N/A
US
Ezenia! Inc
OTC:EZEN
Negative Multiple: -182 667.2 N/A N/A
US
Palantir Technologies Inc
NYSE:PLTR
464.1
137%
3.4
DE
SAP SE
XETRA:SAP
20.6
18%
1.1
US
Salesforce Inc
NYSE:CRM
19.4
24%
0.8
US
Applovin Corp
NASDAQ:APP
60.1
53%
1.1
US
Intuit Inc
NASDAQ:INTU
29.7
27%
1.1
US
Adobe Inc
NASDAQ:ADBE
14.5
16%
0.9
US
N
NCR Corp
LSE:0K45
366.8
16%
22.9
US
Synopsys Inc
NASDAQ:SNPS
72.3
50%
1.4
US
Cadence Design Systems Inc
NASDAQ:CDNS
43.9
27%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
P
Pharmx Technologies Ltd
ASX:PHX
Average EV/EBIT: 206.7
Negative Multiple: -861.4 		N/A N/A
US
Ezenia! Inc
OTC:EZEN
Negative Multiple: -177 298 N/A N/A
US
Palantir Technologies Inc
NYSE:PLTR
478.4
141%
3.4
DE
SAP SE
XETRA:SAP
23.3
21%
1.1
US
Salesforce Inc
NYSE:CRM
26.9
34%
0.8
US
Applovin Corp
NASDAQ:APP
65.3
57%
1.1
US
Intuit Inc
NASDAQ:INTU
34.3
32%
1.1
US
Adobe Inc
NASDAQ:ADBE
15.9
17%
0.9
US
N
NCR Corp
LSE:0K45
1 073
70%
15.3
US
Synopsys Inc
NASDAQ:SNPS
93.6
50%
1.9
US
Cadence Design Systems Inc
NASDAQ:CDNS
49.7
30%
1.7

See Also

Summary
PHX intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHX stock valuation using valuation multiples.
Wall Street Estimates
PHX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.